Ann Kapoun PhD

Ann Kapoun, Ph.D., was promoted to Vice President of Translational Medicine in 2011 and has led the Translations Medicine group at OncoMed as its Senior Director since 2007. The group is responsible for developing biomarker strategies and assays to demonstrate proof of principle in oncology trials. Dr. Kapoun’s expertise is in the clinical execution and implementation of biomarkers and patient stratification approaches. Dr. Kapoun previously spent 10 years building Biomarker and Translational Medicine programs. She served as Associate Director of Biomarker R&D in Clinical Pharmacology & Experimental Medicine at ALZA / Johnson & Johnson. Prior to that she was the Department Head of Biomarker R&D at Scios Inc., where she was responsible for their Biomarker and Pharmacogenomics programs in support of clinical trials. Dr. Kapoun received her Ph.D. from Indiana University, Bloomington, IN, and she has coauthored more than 30 scientific publications and patents.